Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Werner Aberer, Marcus Maurer, Laurence Bouillet, Andrea Zanichelli, Teresa Caballero, Hilary J. Longhurst, Amandine Perrin, Irmgard Andresen, for the IOS Study Group

ABSTRACT

BACKGROUND: Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent attacks. However, despite the use of long-term prophylaxis (LTP), breakthrough attacks are known to occur. We used data from the Icatibant Outcome Survey (IOS) to evaluate the characteristics of breakthrough attacks and the effectiveness of icatibant as a treatment option. METHODS: Data on LTP use, attacks, and treatments were recorded. Attack characteristics, treatment characteristics, and outcomes (time to treatment, time to resolution, and duration of attack) were compared for attacks that occurred with versus without LTP. RESULTS: Data on 3228 icatibant-treated attacks from 448 patients with C1-INH-HAE were analyzed; 30.1% of attacks occurred while patients were using LTP. Attack rate, attack severity, and the distribution of attack sites were similar across all types of LTP used, and were comparable to the results found in patients who did not receive LTP. Attacks were successfully treated with icatibant; 82.5% of all breakthrough attacks were treated with a single icatibant injection without C1-INH rescue medication. Treatment outcomes were comparable for breakthrough attacks across all LTP types, and for attacks without LTP. CONCLUSIONS: Patients who use LTP should be aware that breakthrough attacks can occur, and such attacks can be severe. Thus, patients with C1-INH-HAE using LTP should have emergency treatment readily available. Data from IOS show that icatibant is effective for the treatment of breakthrough attacks. Trial Registration NCT01034969. More... »

PAGES

31

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13223-017-0203-z

DOI

http://dx.doi.org/10.1186/s13223-017-0203-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1090349513

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28690642


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical University of Graz", 
          "id": "https://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Dermatology and Venerology, Medical University of Graz, Auenbruggerplatz 8, A-8036, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aberer", 
        "givenName": "Werner", 
        "id": "sg:person.01203412264.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203412264.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charit\u00e9", 
          "id": "https://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Department of Dermatology and Allergy, Allergie-Centrum-Charit\u00e9, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9platz 1, 10117, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maurer", 
        "givenName": "Marcus", 
        "id": "sg:person.01031146422.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031146422.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Grenoble", 
          "id": "https://www.grid.ac/institutes/grid.410529.b", 
          "name": [
            "National Reference Centre for Angioedema, Internal Medicine Department, Grenoble University Hospital, Boulevard de la Chantourne-CS10217, 38043, Grenoble, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bouillet", 
        "givenName": "Laurence", 
        "id": "sg:person.0720414051.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720414051.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Department of Biomedical and Clinical Sciences Luigi Sacco, ASST Fatebenefratelli Sacco, University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zanichelli", 
        "givenName": "Andrea", 
        "id": "sg:person.01201152347.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201152347.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital La Paz Institute for Health Research", 
          "id": "https://www.grid.ac/institutes/grid.440081.9", 
          "name": [
            "Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Paseo de la Castellana 261, 28046, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caballero", 
        "givenName": "Teresa", 
        "id": "sg:person.01265317451.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265317451.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Barts Health NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.139534.9", 
          "name": [
            "Department of Immunology, Barts Health NHS Trust, 80 Newark Street, E1 2ES, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Longhurst", 
        "givenName": "Hilary J.", 
        "id": "sg:person.0725731432.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725731432.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shire (Switzerland)", 
          "id": "https://www.grid.ac/institutes/grid.476748.e", 
          "name": [
            "Shire, Z\u00e4hlerweg 10, 6300, Zug, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perrin", 
        "givenName": "Amandine", 
        "id": "sg:person.015344641633.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015344641633.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shire (Switzerland)", 
          "id": "https://www.grid.ac/institutes/grid.476748.e", 
          "name": [
            "Shire, Z\u00e4hlerweg 10, 6300, Zug, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Andresen", 
        "givenName": "Irmgard", 
        "id": "sg:person.011610700031.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011610700031.52"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "for the IOS Study Group", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.jaci.2013.03.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004539767"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(11)60935-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005206855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1398-9995.2011.02751.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007245030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14740338.2015.1094053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015511265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0053773", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021725814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/all.12731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022330603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaci.2015.12.907", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026458115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/wox.0b013e318279affa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028774338", 
          "https://doi.org/10.1097/wox.0b013e318279affa"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/wox.0b013e318279affa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028774338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0091-6749(81)90181-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035878526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mej.0000000000000292", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037709588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mej.0000000000000292", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037709588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cei.12584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043564538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197612232952602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044833069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/all.12380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045592020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/all.12060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045653750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2500/aap.2015.36.3892", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046141776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1081-1206(10)60424-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047325695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2012.02.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048812571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0805538", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049004307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/ped.2014.0425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059305215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078972081", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent attacks. However, despite the use of long-term prophylaxis (LTP), breakthrough attacks are known to occur. We used data from the Icatibant Outcome Survey (IOS) to evaluate the characteristics of breakthrough attacks and the effectiveness of icatibant as a treatment option.\nMETHODS: Data on LTP use, attacks, and treatments were recorded. Attack characteristics, treatment characteristics, and outcomes (time to treatment, time to resolution, and duration of attack) were compared for attacks that occurred with versus without LTP.\nRESULTS: Data on 3228 icatibant-treated attacks from 448 patients with C1-INH-HAE were analyzed; 30.1% of attacks occurred while patients were using LTP. Attack rate, attack severity, and the distribution of attack sites were similar across all types of LTP used, and were comparable to the results found in patients who did not receive LTP. Attacks were successfully treated with icatibant; 82.5% of all breakthrough attacks were treated with a single icatibant injection without C1-INH rescue medication. Treatment outcomes were comparable for breakthrough attacks across all LTP types, and for attacks without LTP.\nCONCLUSIONS: Patients who use LTP should be aware that breakthrough attacks can occur, and such attacks can be severe. Thus, patients with C1-INH-HAE using LTP should have emergency treatment readily available. Data from IOS show that icatibant is effective for the treatment of breakthrough attacks. Trial Registration NCT01034969.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13223-017-0203-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1035225", 
        "issn": [
          "1710-1484", 
          "1710-1492"
        ], 
        "name": "Allergy, Asthma & Clinical Immunology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey", 
    "pagination": "31", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a3e9b1eeb6db2f3249d5287e7532a8f58c7681c318d0d76ffac953443361efce"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28690642"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101244313"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13223-017-0203-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1090349513"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13223-017-0203-z", 
      "https://app.dimensions.ai/details/publication/pub.1090349513"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70049_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13223-017-0203-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13223-017-0203-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13223-017-0203-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13223-017-0203-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13223-017-0203-z'


 

This table displays all metadata directly associated to this object as RDF triples.

203 TRIPLES      21 PREDICATES      50 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13223-017-0203-z schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Ne8db7daec3894f30bb42e2425e43233f
4 schema:citation sg:pub.10.1097/wox.0b013e318279affa
5 https://app.dimensions.ai/details/publication/pub.1078972081
6 https://doi.org/10.1016/0091-6749(81)90181-0
7 https://doi.org/10.1016/j.amjmed.2012.02.020
8 https://doi.org/10.1016/j.jaci.2013.03.034
9 https://doi.org/10.1016/j.jaci.2015.12.907
10 https://doi.org/10.1016/s0140-6736(11)60935-5
11 https://doi.org/10.1016/s1081-1206(10)60424-3
12 https://doi.org/10.1056/nejm197612232952602
13 https://doi.org/10.1056/nejmoa0805538
14 https://doi.org/10.1089/ped.2014.0425
15 https://doi.org/10.1097/mej.0000000000000292
16 https://doi.org/10.1097/wox.0b013e318279affa
17 https://doi.org/10.1111/all.12060
18 https://doi.org/10.1111/all.12380
19 https://doi.org/10.1111/all.12731
20 https://doi.org/10.1111/cei.12584
21 https://doi.org/10.1111/j.1398-9995.2011.02751.x
22 https://doi.org/10.1371/journal.pone.0053773
23 https://doi.org/10.1517/14740338.2015.1094053
24 https://doi.org/10.2500/aap.2015.36.3892
25 schema:datePublished 2017-12
26 schema:datePublishedReg 2017-12-01
27 schema:description BACKGROUND: Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent attacks. However, despite the use of long-term prophylaxis (LTP), breakthrough attacks are known to occur. We used data from the Icatibant Outcome Survey (IOS) to evaluate the characteristics of breakthrough attacks and the effectiveness of icatibant as a treatment option. METHODS: Data on LTP use, attacks, and treatments were recorded. Attack characteristics, treatment characteristics, and outcomes (time to treatment, time to resolution, and duration of attack) were compared for attacks that occurred with versus without LTP. RESULTS: Data on 3228 icatibant-treated attacks from 448 patients with C1-INH-HAE were analyzed; 30.1% of attacks occurred while patients were using LTP. Attack rate, attack severity, and the distribution of attack sites were similar across all types of LTP used, and were comparable to the results found in patients who did not receive LTP. Attacks were successfully treated with icatibant; 82.5% of all breakthrough attacks were treated with a single icatibant injection without C1-INH rescue medication. Treatment outcomes were comparable for breakthrough attacks across all LTP types, and for attacks without LTP. CONCLUSIONS: Patients who use LTP should be aware that breakthrough attacks can occur, and such attacks can be severe. Thus, patients with C1-INH-HAE using LTP should have emergency treatment readily available. Data from IOS show that icatibant is effective for the treatment of breakthrough attacks. Trial Registration NCT01034969.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N0b4fecf5ac5a4b28986c980337cf4f13
32 Nb25b4b5b053c4e46b687c032c6e66971
33 sg:journal.1035225
34 schema:name Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
35 schema:pagination 31
36 schema:productId N1f3c41e3989242438963b20af0c40b13
37 N3897b899c913435181c89decf0942669
38 N80041ef38dc847e7a577ec9a869be9e5
39 Nb6b1d1fab74e4749864a949c1607a170
40 Nd139dcd8450e49c3a3acc77e4eb31bc6
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090349513
42 https://doi.org/10.1186/s13223-017-0203-z
43 schema:sdDatePublished 2019-04-11T12:40
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N4b4337c7d5054ac1b6307c10cd4ab3ba
46 schema:url https://link.springer.com/10.1186%2Fs13223-017-0203-z
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N0b3550e8ad7d4d5ca5621a5dc8773782 rdf:first sg:person.0720414051.29
51 rdf:rest Nb05924295c9441db98b83814c72729a7
52 N0b4fecf5ac5a4b28986c980337cf4f13 schema:issueNumber 1
53 rdf:type schema:PublicationIssue
54 N1f3c41e3989242438963b20af0c40b13 schema:name nlm_unique_id
55 schema:value 101244313
56 rdf:type schema:PropertyValue
57 N2217a74803a1494392be5b9a293d2dd1 rdf:first Ne109b391ba244dfda157279d9fae5c78
58 rdf:rest rdf:nil
59 N2d21ae146fa7413d8b9d2b3da8310e9e rdf:first sg:person.015344641633.51
60 rdf:rest N408ba4de5fda4c038b3392fdf34d96d8
61 N3897b899c913435181c89decf0942669 schema:name dimensions_id
62 schema:value pub.1090349513
63 rdf:type schema:PropertyValue
64 N408ba4de5fda4c038b3392fdf34d96d8 rdf:first sg:person.011610700031.52
65 rdf:rest N2217a74803a1494392be5b9a293d2dd1
66 N4b4337c7d5054ac1b6307c10cd4ab3ba schema:name Springer Nature - SN SciGraph project
67 rdf:type schema:Organization
68 N80041ef38dc847e7a577ec9a869be9e5 schema:name readcube_id
69 schema:value a3e9b1eeb6db2f3249d5287e7532a8f58c7681c318d0d76ffac953443361efce
70 rdf:type schema:PropertyValue
71 N831cfd6af2da45ffbfaa0202c59e5eba rdf:first sg:person.01265317451.05
72 rdf:rest Nafe8512740224ab7b5a6c933e6c67c00
73 Nafe8512740224ab7b5a6c933e6c67c00 rdf:first sg:person.0725731432.69
74 rdf:rest N2d21ae146fa7413d8b9d2b3da8310e9e
75 Nb05924295c9441db98b83814c72729a7 rdf:first sg:person.01201152347.07
76 rdf:rest N831cfd6af2da45ffbfaa0202c59e5eba
77 Nb25b4b5b053c4e46b687c032c6e66971 schema:volumeNumber 13
78 rdf:type schema:PublicationVolume
79 Nb6b1d1fab74e4749864a949c1607a170 schema:name pubmed_id
80 schema:value 28690642
81 rdf:type schema:PropertyValue
82 Nd139dcd8450e49c3a3acc77e4eb31bc6 schema:name doi
83 schema:value 10.1186/s13223-017-0203-z
84 rdf:type schema:PropertyValue
85 Ne109b391ba244dfda157279d9fae5c78 schema:familyName for the IOS Study Group
86 rdf:type schema:Person
87 Ne8c38dbb900b43379c1e87dcf834ebd6 rdf:first sg:person.01031146422.30
88 rdf:rest N0b3550e8ad7d4d5ca5621a5dc8773782
89 Ne8db7daec3894f30bb42e2425e43233f rdf:first sg:person.01203412264.96
90 rdf:rest Ne8c38dbb900b43379c1e87dcf834ebd6
91 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
92 schema:name Medical and Health Sciences
93 rdf:type schema:DefinedTerm
94 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
95 schema:name Public Health and Health Services
96 rdf:type schema:DefinedTerm
97 sg:journal.1035225 schema:issn 1710-1484
98 1710-1492
99 schema:name Allergy, Asthma & Clinical Immunology
100 rdf:type schema:Periodical
101 sg:person.01031146422.30 schema:affiliation https://www.grid.ac/institutes/grid.6363.0
102 schema:familyName Maurer
103 schema:givenName Marcus
104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031146422.30
105 rdf:type schema:Person
106 sg:person.011610700031.52 schema:affiliation https://www.grid.ac/institutes/grid.476748.e
107 schema:familyName Andresen
108 schema:givenName Irmgard
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011610700031.52
110 rdf:type schema:Person
111 sg:person.01201152347.07 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
112 schema:familyName Zanichelli
113 schema:givenName Andrea
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201152347.07
115 rdf:type schema:Person
116 sg:person.01203412264.96 schema:affiliation https://www.grid.ac/institutes/grid.11598.34
117 schema:familyName Aberer
118 schema:givenName Werner
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203412264.96
120 rdf:type schema:Person
121 sg:person.01265317451.05 schema:affiliation https://www.grid.ac/institutes/grid.440081.9
122 schema:familyName Caballero
123 schema:givenName Teresa
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265317451.05
125 rdf:type schema:Person
126 sg:person.015344641633.51 schema:affiliation https://www.grid.ac/institutes/grid.476748.e
127 schema:familyName Perrin
128 schema:givenName Amandine
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015344641633.51
130 rdf:type schema:Person
131 sg:person.0720414051.29 schema:affiliation https://www.grid.ac/institutes/grid.410529.b
132 schema:familyName Bouillet
133 schema:givenName Laurence
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720414051.29
135 rdf:type schema:Person
136 sg:person.0725731432.69 schema:affiliation https://www.grid.ac/institutes/grid.139534.9
137 schema:familyName Longhurst
138 schema:givenName Hilary J.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725731432.69
140 rdf:type schema:Person
141 sg:pub.10.1097/wox.0b013e318279affa schema:sameAs https://app.dimensions.ai/details/publication/pub.1028774338
142 https://doi.org/10.1097/wox.0b013e318279affa
143 rdf:type schema:CreativeWork
144 https://app.dimensions.ai/details/publication/pub.1078972081 schema:CreativeWork
145 https://doi.org/10.1016/0091-6749(81)90181-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035878526
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/j.amjmed.2012.02.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048812571
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1016/j.jaci.2013.03.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004539767
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/j.jaci.2015.12.907 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026458115
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/s0140-6736(11)60935-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005206855
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/s1081-1206(10)60424-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047325695
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1056/nejm197612232952602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044833069
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1056/nejmoa0805538 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049004307
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1089/ped.2014.0425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059305215
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1097/mej.0000000000000292 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037709588
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1097/wox.0b013e318279affa schema:sameAs https://app.dimensions.ai/details/publication/pub.1028774338
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1111/all.12060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045653750
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1111/all.12380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045592020
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1111/all.12731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022330603
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1111/cei.12584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043564538
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1111/j.1398-9995.2011.02751.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007245030
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1371/journal.pone.0053773 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021725814
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1517/14740338.2015.1094053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015511265
180 rdf:type schema:CreativeWork
181 https://doi.org/10.2500/aap.2015.36.3892 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046141776
182 rdf:type schema:CreativeWork
183 https://www.grid.ac/institutes/grid.11598.34 schema:alternateName Medical University of Graz
184 schema:name Department of Dermatology and Venerology, Medical University of Graz, Auenbruggerplatz 8, A-8036, Graz, Austria
185 rdf:type schema:Organization
186 https://www.grid.ac/institutes/grid.139534.9 schema:alternateName Barts Health NHS Trust
187 schema:name Department of Immunology, Barts Health NHS Trust, 80 Newark Street, E1 2ES, London, UK
188 rdf:type schema:Organization
189 https://www.grid.ac/institutes/grid.410529.b schema:alternateName Centre Hospitalier Universitaire de Grenoble
190 schema:name National Reference Centre for Angioedema, Internal Medicine Department, Grenoble University Hospital, Boulevard de la Chantourne-CS10217, 38043, Grenoble, France
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.440081.9 schema:alternateName Hospital La Paz Institute for Health Research
193 schema:name Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Paseo de la Castellana 261, 28046, Madrid, Spain
194 rdf:type schema:Organization
195 https://www.grid.ac/institutes/grid.4708.b schema:alternateName University of Milan
196 schema:name Department of Biomedical and Clinical Sciences Luigi Sacco, ASST Fatebenefratelli Sacco, University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy
197 rdf:type schema:Organization
198 https://www.grid.ac/institutes/grid.476748.e schema:alternateName Shire (Switzerland)
199 schema:name Shire, Zählerweg 10, 6300, Zug, Switzerland
200 rdf:type schema:Organization
201 https://www.grid.ac/institutes/grid.6363.0 schema:alternateName Charité
202 schema:name Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany
203 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...